Skip to main content
ZYME logo
ZYME
(NASDAQ)
Zymeworks Inc.
$25.80-- (--)
Loading... - Market loading

Zymeworks (ZYME) Stock Price & Financial Analysis

Zymeworks Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$25.50 - $26.72
52-Week High$28.49
52-Week Low$9.03
Open$25.56
Volume701.73K
Average Volume (3M)701.73K
Market Cap1.94B
Shares Outstanding75.34M
Price to Sales (P/S)18.44
Price to Book (P/B)7.28
EV/EBITDA-20.75
Revenue (TTM)105.97M
Net Income (TTM)-81.13M
Free Cash Flow (TTM)-34.93M
EPS (TTM)$-1.08
Profit Margin-76.56%
Operating Margin-87.26%
Return on Equity (ROE)-30.22%
Debt to Equity0.07
50-Day MA$23.59
200-Day MA$19.53
52-Week Change123.24%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Zymeworks

What is the current stock price for ZYME?

As of the latest trading session, ZYME stock trades at $25.80. The 52-week range is $9.03–$28.49, with a day range of $25.50–$26.72.

What is the P/E ratio for ZYME?

The P/E ratio (Price-to-Earnings) for ZYME is shown in the Key Statistics section. This valuation metric helps compare Zymeworks Inc. to industry peers.

Does ZYME pay dividends?

Zymeworks does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ZYME?

Based on 9 analysts, the consensus for ZYME is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of ZYME?

Zymeworks's market capitalization is $1.94B, classifying it as a small-cap company. Zymeworks operates in the Healthcare sector within the Biotechnology industry.